Concepedia

A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade

Andrej Ozaniak, Jitka Smetanová, Robin Bartolini, Michal Rataj, Linda Čapková, Jaromír Háček, Martina Fialová, Lenka Krupickova, Robert Lischke, Jiřina Bartůňková,

Journal of Cancer Research and Clinical Oncology · 2022 · 16 citations · 32 references

DOI

Concepts

References

32

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

Mark P. Chao, Ash A. Alizadeh, Chad Tang et al. · Cell · 2010 · 1.1K citations · Full text

, , +14

Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

Cell · 2017 · 1.1K citations · Full text

, , +14

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Christopher Garris, Sean P. Arlauckas, Rainer H. Köhler et al. · Immunity · 2018 · 937 citations · Full text

, , +12

Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

Diane Tseng, Jens-Peter Volkmer, Stephen B. Willingham et al. · Proceedings of the National Academy of Sciences · 2013 · 649 citations · Full text

, , +17

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo et al. · The Lancet Oncology · 2017 · 489 citations

, , +17